Emily Riehm Meier1,2, Jacqueline V Dioguardi1, Naynesh Kamani1. 1. Center for Cancer and Blood Disorders, Children's National Medical Center, Washington, DC, 20010. 2. Department of Pediatrics, The George Washington University School of Medicine and Health Sciences, Washington, DC.
Abstract
BACKGROUND: Allogeneic hematopoietic stem cell transplantation (HSCT) is the only available cure for sickle cell anemia (SCA). HSCT-associated risks are one of many barriers to its widespread use for SCA. The study objective was to assess parent and patient perceptions of HSCT in the era of more widespread knowledge about HSCT for SCA. PROCEDURE: We surveyed parents of children with SCA and adolescents with SCA using the standard reference gamble paradigm. Survey responses between Africans (A) and African Americans (AA) and between parents and adolescents were compared. RESULTS: Seventy-two percent (64/89) of the respondents were willing to accept ≥ 5% risk of mortality, while 57% said they would accept a risk of ≥ 10% of graft versus host disease (GVHD). Twenty-two percent were unwilling to accept any risk of mortality or GVHD. Risk averseness did not differ between A or AA respondents. Fifty-six percent of respondents were willing to accept infertility post-HSCT. CONCLUSIONS: These data suggest that the majority of parents and adolescents are willing to accept the current risks associated with matched sibling HSCT for SCA. However, there continue to be significant numbers of parents and adolescents who are unwilling to accept any risk of HSCT-associated mortality or GVHD.
BACKGROUND: Allogeneic hematopoietic stem cell transplantation (HSCT) is the only available cure for sickle cell anemia (SCA). HSCT-associated risks are one of many barriers to its widespread use for SCA. The study objective was to assess parent and patient perceptions of HSCT in the era of more widespread knowledge about HSCT for SCA. PROCEDURE: We surveyed parents of children with SCA and adolescents with SCA using the standard reference gamble paradigm. Survey responses between Africans (A) and African Americans (AA) and between parents and adolescents were compared. RESULTS: Seventy-two percent (64/89) of the respondents were willing to accept ≥ 5% risk of mortality, while 57% said they would accept a risk of ≥ 10% of graft versus host disease (GVHD). Twenty-two percent were unwilling to accept any risk of mortality or GVHD. Risk averseness did not differ between A or AA respondents. Fifty-six percent of respondents were willing to accept infertility post-HSCT. CONCLUSIONS: These data suggest that the majority of parents and adolescents are willing to accept the current risks associated with matched sibling HSCT for SCA. However, there continue to be significant numbers of parents and adolescents who are unwilling to accept any risk of HSCT-associated mortality or GVHD.
Authors: Robert Sheppard Nickel; Jacqueline Y Maher; Michael H Hsieh; Meghan F Davis; Matthew M Hsieh; Lydia H Pecker Journal: J Clin Med Date: 2022-04-21 Impact factor: 4.964
Authors: Lydia H Pecker; Sarah Kappa; Adam Greenfest; Deepika S Darbari; Robert Sheppard Nickel Journal: J Pediatr Date: 2018-06-29 Impact factor: 4.406
Authors: Staci D Arnold; Ruta Brazauskas; Naya He; Yimei Li; Richard Aplenc; Zhezhen Jin; Matt Hall; Yoshiko Atsuta; Jignesh Dalal; Theresa Hahn; Nandita Khera; Carmem Bonfim; Navneet S Majhail; Miguel Angel Diaz; Cesar O Freytes; William A Wood; Bipin N Savani; Rammurti T Kamble; Susan Parsons; Ibrahim Ahmed; Keith Sullivan; Sara Beattie; Christopher Dandoy; Reinhold Munker; Susana Marino; Menachem Bitan; Hisham Abdel-Azim; Mahmoud Aljurf; Richard F Olsson; Sarita Joshi; Dave Buchbinder; Michael J Eckrich; Shahrukh Hashmi; Hillard Lazarus; David I Marks; Amir Steinberg; Ayman Saad; Usama Gergis; Lakshmanan Krishnamurti; Allistair Abraham; Hemalatha G Rangarajan; Mark Walters; Joseph Lipscomb; Wael Saber; Prakash Satwani Journal: Haematologica Date: 2017-08-17 Impact factor: 9.941
Authors: Santosh L Saraf; Annie L Oh; Pritesh R Patel; Karen Sweiss; Matthew Koshy; Sally Campbell-Lee; Michel Gowhari; Shivi Jain; David Peace; John G Quigley; Irum Khan; Robert E Molokie; Nadim Mahmud; Victor R Gordeuk; Damiano Rondelli Journal: Biol Blood Marrow Transplant Date: 2018-04-12 Impact factor: 5.742